Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report

Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), downbeat nystagmus and Tourette syndrome. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS, CMS and myasthenia gravis; CPP-115, a GABA aminotransferase inhibitor for central nervous system (CNS) indications, such as infantile spasms, epilepsy and Tourette syndrome; and CPP-109, a generic version of Sabril for Tourette’s disorder. Catalyst is headquartered in Coral Gables, Florida, the US.

Scope

  • Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments
  • News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

ReceptoPharm Inc

Psyadon Pharmaceuticals Inc

Pfizer Inc

Marinus Pharmaceuticals Inc

Marathon Pharmaceuticals LLC

Jacobus Pharmaceutical Company

GlaxoSmithKline Plc

ReceptoPharm Inc

Psyadon Pharmaceuticals Inc

Pfizer Inc

Marinus Pharmaceuticals Inc

Marathon Pharmaceuticals LLC

Jacobus Pharmaceutical Company

GlaxoSmithKline Plc

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Catalyst Pharmaceuticals Inc ...

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Catalyst Pharmaceuticals Inc - Key Facts 6

Catalyst Pharmaceuticals Inc - Key Employees 7

Catalyst Pharmaceuticals Inc - Key Employee Biographies 8

Catalyst Pharmaceuticals Inc - Major Products and Services 9

Catalyst Pharmaceuticals Inc - History 10

Catalyst Pharmaceuticals Inc - Company Statement 12

Catalyst Pharmaceuticals Inc - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 – Company Analysis 14

Company Overview 14

Catalyst Pharmaceuticals Inc - Business Description 15

Catalyst Pharmaceuticals Inc - Corporate Strategy 16

Catalyst Pharmaceuticals Inc - SWOT Analysis 17

SWOT Analysis - Overview 17

Catalyst Pharmaceuticals Inc - Strengths 17

Catalyst Pharmaceuticals Inc - Weaknesses 18

Catalyst Pharmaceuticals Inc - Opportunities 19

Catalyst Pharmaceuticals Inc - Threats 20

Catalyst Pharmaceuticals Inc - Key Competitors 21

Section 3 – Company Financial Ratios 22

Financial Ratios - Capital Market Ratios 22

Financial Ratios - Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios - Interim Ratios 26

Financial Ratios - Ratio Charts 27

Section 4 – Company’s Lifesciences Financial Deals and Alliances 28

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Catalyst Pharmaceuticals Inc, Recent Deals Summary 30

Section 5 – Company’s Recent Developments 31

Aug 07, 2018: Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update 31

Aug 06, 2018: Catalyst Pharmaceuticals expands commercial leadership team 33

May 23, 2018: CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease 34

May 09, 2018: Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update 35

Mar 14, 2018: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update 36

Nov 08, 2017: Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update 38

Oct 26, 2017: Catalyst Biosciences Announces the Appointment of Industry Veteran Andrea Hunt to its Board of Directors 39

Aug 09, 2017: Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update 40

May 10, 2017: Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update 42

Mar 15, 2017: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update 43

Section 6 – Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Tables

List of Tables

Catalyst Pharmaceuticals Inc, Key Facts 6

Catalyst Pharmaceuticals Inc, Key Employees 7

Catalyst Pharmaceuticals Inc, Key Employee Biographies 8

Catalyst Pharmaceuticals Inc, ...

List of Tables

Catalyst Pharmaceuticals Inc, Key Facts 6

Catalyst Pharmaceuticals Inc, Key Employees 7

Catalyst Pharmaceuticals Inc, Key Employee Biographies 8

Catalyst Pharmaceuticals Inc, Major Products and Services 9

Catalyst Pharmaceuticals Inc, History 10

Catalyst Pharmaceuticals Inc, Subsidiaries 13

Catalyst Pharmaceuticals Inc, Key Competitors 21

Catalyst Pharmaceuticals Inc, Ratios based on current share price 22

Catalyst Pharmaceuticals Inc, Annual Ratios 23

Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...1) 24

Catalyst Pharmaceuticals Inc, Interim Ratios 26

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Catalyst Pharmaceuticals Inc, Recent Deals Summary 30

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

List of Figures

List of Figures

Catalyst Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25

Catalyst Pharmaceuticals Inc, Ratio Charts 27

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals ...

List of Figures

Catalyst Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25

Catalyst Pharmaceuticals Inc, Ratio Charts 27

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports